19-7134002-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.2683-1685G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.18 in 152,010 control chromosomes in the GnomAD database, including 3,389 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 3389 hom., cov: 33)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.58

Publications

4 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.483 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000208.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
NM_000208.4
MANE Select
c.2683-1685G>A
intron
N/ANP_000199.2
INSR
NM_001079817.3
c.2647-1685G>A
intron
N/ANP_001073285.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
ENST00000302850.10
TSL:1 MANE Select
c.2683-1685G>A
intron
N/AENSP00000303830.4
INSR
ENST00000341500.9
TSL:1
c.2647-1685G>A
intron
N/AENSP00000342838.4
INSR
ENST00000904791.1
c.2683-1685G>A
intron
N/AENSP00000574850.1

Frequencies

GnomAD3 genomes
AF:
0.180
AC:
27322
AN:
151892
Hom.:
3376
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.288
Gnomad AMI
AF:
0.219
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.125
Gnomad EAS
AF:
0.498
Gnomad SAS
AF:
0.125
Gnomad FIN
AF:
0.157
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.0864
Gnomad OTH
AF:
0.175
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.180
AC:
27376
AN:
152010
Hom.:
3389
Cov.:
33
AF XY:
0.187
AC XY:
13915
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.288
AC:
11936
AN:
41450
American (AMR)
AF:
0.242
AC:
3687
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
435
AN:
3472
East Asian (EAS)
AF:
0.499
AC:
2580
AN:
5170
South Asian (SAS)
AF:
0.125
AC:
602
AN:
4818
European-Finnish (FIN)
AF:
0.157
AC:
1661
AN:
10554
Middle Eastern (MID)
AF:
0.133
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
0.0863
AC:
5869
AN:
67980
Other (OTH)
AF:
0.174
AC:
368
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1065
2129
3194
4258
5323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
4301
Bravo
AF:
0.195
Asia WGS
AF:
0.284
AC:
988
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.47
DANN
Benign
0.44
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10420382; hg19: chr19-7134013; API